Claims for Patent: 3,666,858

Summary for Patent: 3,666,858

Title:	UTILIZATION OF GON-4-ENE THERAPY IN TREATMENT OF FEMALES AND IN GROWTH STIMULATION
Abstract:	Methods of using certain 13-ethyl-gon-4-enes are described, namely 13.beta.,17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one, and the decanoate ester of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one for growth stimulation in mammals; and 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one, to treat dysfunctions of the female reproductive system in mammals, to control cyclic regularity, and to prevent conception in female mammals.
Inventor(s):	Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA)
Assignee:	SAID Smith, by said Hughes (N/A)
Application Number:	04/649,800
Patent Claims:	1. A composition, useful for stimulating growth of a mammal, comprising an effective growth-stimulating amount of a compound, selected from the group consisting of 13.beta., 17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one and 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one 17-decanoate, and a pharmaceutically acceptable carrier. 2. A composition, useful for cyclic control in a female mammal, and for treatment of dysfunctions of the female reproductive system in a mammal, said dysfunctions being selected from the group consisting of amenorrhea, dysmenorrhea, and functional uterine bleeding, comprising an amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.eta.-hydroxygon-4-en-3-one effective for the said purpose and a pharmaceutically acceptable carrier. 3. Composition of claim 2, wherein the amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one is about 2.5 to about 25 mg. 4. A composition, useful for preventing conception in a female mammal, comprising an amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one between about 0.015 and about 10 mg., effective for said purpose and a pharmaceutically acceptable carrier. 5. Composition of claim 4, wherein the amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one is about 0.015 to about 1 mg. 6. A composition, useful for preventing conception in a female mammal, comprising an amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one effective to prevent conception and up to about 0.05 mg. of ethynyl estradiol. 7. A method of stimulating growth in a mammal which comprises administering to said mammal a growth stimulating amount of 13.beta., 17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one. 8. A method of stimulating growth in a mammal which comprises administering to said mammal a growth stimulating amount of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one 17-decanoate. 9. A method for cyclic control in a female mammal and treatment of dysfunctions of the female reproductive system in a mammal, said dysfunctions being selected from the group consisting of amenorrhea, dysmenorrhea, and functional uterine bleeding, which comprises orally administering to said mammal a pharmaceutically effective amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one. 10. A method of preventing conception in a female mammal which comprises orally administering to said mammal 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one in an effective amount of 0.015 mg. to about 10 mg. per day. 11. A method of preventing conception in a female mammal which comprises orally administering to said mammal an effective amount of about 0.015 mg. to about 1 mg. per day of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one on a continuous basis. 12. A method of preventing conception in a female mammal which comprises orally administering to said mammal an amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one effective to prevent conception in combination with up to about .05 mg. of ethynyl estradiol per day on a cyclic basis. 13. A method for control of gynecomastia in a male human which comprises administering to said male human an amount of 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one effective for said purpose.